Rights and permissions
About this article
Cite this article
IFN-Β-1a cost effective long term for multiple sclerosis. Pharmacoecon. Outcomes News 428, 5 (2003). https://doi.org/10.1007/BF03276719
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276719